Gossamer Bio Inc Share Price Today: Live Updates & Key Insights

Gossamer Bio Inc share price today is $0.1341, up -4.56%. The stock opened at $0.1411 against the previous close of $0.1425, with an intraday high of $0.1416 and low of $0.1323.

Gossamer Bio Inc Share Price Chart

Gossamer Bio Inc

us-stock
To Invest in {{usstockname}}
us-stock

Gossamer Bio Inc Share Price Performance

$0.1341 -0.0456(-4.56%) GOSS at 27 Jul 2026 03:21 PM Biotechnology
Lowest Today 0.1323
Highest Today 0.1416
Today’s Open 0.1411
Prev. Close 0.1425
52 Week High 3.87
52 Week Low 0.11
Day’s Range: Low 0.1323 High 0.1416
52-Week Range: Low 0.11 High 3.87
1 day return -
1 Week return -3.98
1 month return -14.94
3 month return -61.24
6 month return -94.9
1 year return -93.2
3 year return -89.2
5 year return -98.22
10 year return -

Gossamer Bio Inc Institutional Holdings

Kalehua Capital Management LLC 3.62

BlackRock Inc 3.44

Vanguard Group Inc 2.63

AQR Capital Management LLC 2.07

Vanguard Capital Management, LLC 1.92

ARCH VENTURE CORP 1.65

Octagon Capital Advisors LP 1.59

Samsara BioCapital, LLC 1.48

Vanguard Total Stock Mkt Idx Inv 1.41

Balyasny Asset Management LLC 1.21

Acadian Asset Management LLC 1.08

Siren, L.L.C. 1.07

683 Capital Management LLC 1.02

Hillhouse Capital Advisors, Ltd. 1.02

Geode Capital Management, LLC 1.01

Qube Research & Technologies 1.01

Two Sigma Investments LLC 0.98

State Street Corp 0.90

CI Private Wealth LLC 0.82

Squarepoint Ops LLC 0.70

GSA Capital Partners LLP 0.67

Vanguard Institutional Extnd Mkt Idx Tr 0.46

Fidelity Small Cap Index 0.38

iShares Biotechnology ETF 0.31

Mackenzie Quantitative US Small Cap 0.26

Russell 2000 Equity Index Fund B 0.25

Russell 2000 Index Non-Lendable Fund 0.25

Fidelity Extended Market Index 0.24

Xtrackers S&P 500 Swap ETF 1C 0.22

Schwab US Small-Cap ETF™ 0.20

Federated Hermes Kaufmann Small Cap A 0.16

Federated Hermes Kaufmann Small Cap Grow 0.16

Extended Equity Market Fund B 0.11

Extended Equity Market Fund E 0.11

Blackrock Extended Mkt Fund CF 0.11

Vanguard Health Care ETF 0.11

BlackRock Extended Equity Market Fund K 0.10

Invesco RAFI US 1500 Small-Mid ETF 0.09

Schwab Small Cap Index 0.08

Vanguard Explorer Inv 0.08

Gossamer Bio Inc Market Status

Strong Buy: 4

Buy: 3

Hold: 2

Sell: 0

Strong Sell: 0

Gossamer Bio Inc Fundamentals

Market Cap 69.66 M

PB Ratio 2.6638

PE Ratio 0.0

Enterprise Value 174.41 M

Total Assets 172.25 M

Volume 10925773

Gossamer Bio Inc Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-187433000 -187.4M, FY22:-240228000 -240.2M, FY21:-249076000 -249.1M, FY20:-251584000 -251.6M, FY19:-180818000 -180.8M

Quarterly Revenue Q1/2026:16955000 17.0M, Q3/2025:13294000 13.3M, Q2/2025:11489000 11.5M, Q1/2025:9889000 9.9M, Q3/2024:9480000 9.5M

Quarterly Profit Q1/2026:16722999 16.7M, Q3/2025:13294000 13.3M, Q2/2025:11489000 11.5M, Q1/2025:9889000 9.9M, Q3/2024:9480000 9.5M

Quarterly Net worth Q1/2026:-46664000 -46.7M, Q3/2025:-48221000 -48.2M, Q2/2025:-38273000 -38.3M, Q1/2025:-36638000 -36.6M, Q3/2024:-30803000 -30.8M

About Gossamer Bio Inc & investment objective

Company Information Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary hypertension and pulmonary arterial hypertension in the United States. The company develops GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony-stimulatin factor 1 receptor and c-KIT inhibitor, which is in Phase 3 clinical trial for the treatment of PAH. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. The company was incorporated in 2015 and is headquartered in San Diego, California.

Organisation Biotechnology

Employees 161

Industry Biotechnology

CEO Mr. Faheem Hasnain

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Gossamer Bio Inc FAQs

What is the share price of Gossamer Bio Inc today?

The current share price of Gossamer Bio Inc is $0.1341.

Can I buy Gossamer Bio Inc shares in India?

Yes, Indian investors can buy Gossamer Bio Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Gossamer Bio Inc shares in India?

You can easily invest in Gossamer Bio Inc shares from India by:

Can I buy fractional shares of Gossamer Bio Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Gossamer Bio Inc?

Gossamer Bio Inc has a market cap of $69.66 M.

In which sector does Gossamer Bio Inc belong?

Gossamer Bio Inc operates in the Biotechnology sector.

What documents are required to invest in Gossamer Bio Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Gossamer Bio Inc?

The PE ratio of Gossamer Bio Inc is N/A and the PB ratio is 2.66.